Farmakoterapia w Psychiatrii i Neurologii

Pełna treść

1/2025 vol. 41
Artykuł przeglądowy

Terapeutyczne implikacje senoterapii w chorobach neurodegeneracyjnych: od podstaw molekularnych do perspektyw klinicznych

Cezary Mydlak 1
,
Krzysztof Książek 2
  1. Poznan University of Medical Sciences, Department of Pathophysiology of Ageing and Civilization Diseases, Poznan, Poland
  2. Prince Mieszko I Poznan Medical University of Applied Sciences, Faculty of Medical Sciences, Poznan, Poland
Farmakoterapia w Psychiatrii i Neurologii 2025, 41 (1), 9–18
DOI: https://doi.org/10.5114/fpn.2025.154611
Data publikacji online: 2025/10/30
Plik artykułu
1D0_IPiN_FARM_2025-1C.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Baker DJ and Petersen RC. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. The Journal of clinical investigation 2018; 128: 1208-1216.
  2. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-236.
  3. Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU et al. Astrocyte Senescence as a Component of Alzheimer’s Disease. PLOS ONE 2012; 7: e45069-e45069.
  4. Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM and Baker DJ Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 2018; 562: 578-582.
  5. Caccamo A, Majumder S, Richardson A, Strong R and Oddo S. Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau. Journal of Biological Chemistry 2010; 285: 13107-13120.
  6. Cook M, Lin H, Mishra SK and Wang GY. BAY 11-7082 inhibits the secretion of interleukin-6 by senescent human microglia. Biochem Biophys Res Commun 2022; 617: 30-35.
  7. Cornell J, Salinas S, Huang HY and Zhou M. Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 2022; 17: 705-716.
  8. Cui Y, Wu J, Jung S-C, Park D-B, Maeng Y-H, Hong JY et al. Anti-neuroinflammatory Activity of Nobiletin on Suppression of Microglial Activation. Biological and Pharmaceutical Bulletin 2010; 33: 1814-1821.
  9. Frank-Cannon TC, Alto LT, McAlpine FE and Tansey MG. Does neuroinflammation fan the flame in neurodegenerative diseases? Molecular Neurodegeneration 2009; 4: 1-13.
  10. Fuhrmann-Stroissnigg H, Ling YY, Zhao J, McGowan SJ, Zhu Y, Brooks RW et al. Identification of HSP90 inhibitors as a novel class of senolytics. Nature Communications 2017; 8 (1): 422.
  11. Gonzales MM, Garbarino VR, Kautz T, Palavicini JP, Lopez-Cruzan M, Dehkordi SK et al. Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Res Sq 2023.
  12. Goodman Y, Steiner MR, Steiner SM and Mattson MP. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 1994; 654: 171-176.
  13. Guerrero A, De Strooper B and Arancibia-Cárcamo IL Cellular senescence at the crossroads of inflammation and Alzheimer's disease. Trends in Neurosciences 2021; 44: 714-727.
  14. He Y, Li W, Lv D, Zhang X, Zhang X, Ortiz YT et al. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity. Aging Cell 2020; 19: e13117.
  15. Herdy JR, Mertens J and Gage FH Neuronal senescence may drive brain aging. Science 2024; 384: 1404-1406.
  16. Huang W, Hickson LJ, Eirin A, Kirkland JL and Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol 2022; 18: 611-627.
  17. Jagaraj CJ, Shadfar S, Kashani SA, Saravanabavan S, Farzana F and Atkin JD. Molecular hallmarks of ageing in amyotrophic lateral sclerosis. Cellular and Molecular Life Sciences 2024; 81 (1): 111.
  18. Karabag D, Scheiblich H, Griep A, Santarelli F, Schwartz S, Heneka MT et al. Characterizing microglial senescence: Tau as a key player. Journal of Neurochemistry 2023; 166: 517-533.
  19. Kesidou E, Theotokis P, Damianidou O, Boziki M, Konstantinidou N, Taloumtzis C et al. CNS Ageing in Health and Neurodegenerative Disorders. J Clin Med 2023; 12 (6): 2255.
  20. Lee HJ, Yoon YS and Lee SJ Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases. Journal of Molecular Biology 2023; 435: 168114-168114.
  21. Lee S, Wang EY, Steinberg AB, Walton CC, Chinta SJ and Andersen JK. A guide to senolytic intervention in neurodegenerative disease HHS Public Access. Mech Ageing Dev 2021; 111585-111585.
  22. Lopes-Paciencia S, Saint-Germain E, Rowell MC, Ruiz AF, Kalegari P and Ferbeyre G. The senescence-associated secretory phenotype and its regulation. Cytokine 2019; 117: 15-22.
  23. Lu L, Tang L, Wei W, Hong Y, Chen H, Ying W et al. Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease. Experimental and Therapeutic Medicine 2014; 8: 943-950.
  24. Lu M, Su C, Qiao C, Bian Y, Ding J and Hu G. Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance. Int J Neuropsychopharmacol 2016; 19 (9): pyw047.
  25. Matsubayashi S, Ito S, Araya J and Kuwano K. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases. Front Endocrinol (Lausanne) 2023; 14: 1079626.
  26. Matsudaira T, Nakano S, Konishi Y, Kawamoto S, Uemura K, Kondo T et al. Cellular senescence in white matter microglia is induced during ageing in mice and exacerbates the neuroinflammatory phenotype. Communications Biology 2023; 6: 665.
  27. Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013; 36: 2981-2987.
  28. Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 2018; 17: e12840.
  29. Nakajima A and Ohizumi Y. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer’s Disease and Parkinson’s Disease. International Journal of Molecular Sciences 2019; 20: 3380.
  30. Pandravada S and Sandler S. The Role of Navitoclax in Myelofibrosis. Cureus 2021; 13 (9): e17976.
  31. Papadopoli D, Boulay K, Kazak L, Pollak M, Mallette FA, Topisirovic I et al. mTOR as a central regulator of lifespan and aging. F1000Res 2019; 8.
  32. Patil SP, Jain PD, Ghumatkar PJ, Tambe R and Sathaye S. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Neuroscience 2014; 277: 747-754.
  33. Peters R Ageing and the brain. Postgrad Med J 2006; 82: 84-88.
  34. Raffaele M and Vinciguerra M. The costs and benefits of senotherapeutics for human health. Lancet Healthy Longev 2022; 3: e67-e77.
  35. Riessland M, Ximerakis M, Jarjour AA, Zhang B and Orr ME. Therapeutic targeting of senescent cells in the CNS. Nat Rev Drug Discov 2024; 23: 817-837.
  36. Rim C, You M-J, Nahm M and Kwon M-S. Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Translational Neurodegeneration 2024; 13: 10.
  37. Samaras K, Makkar S, Crawford JD, Kochan NA, Wen W, Draper B et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study. Diabetes Care 2020; 43: 2691-2701.
  38. Shishido Y, Furushiro M, Hashimoto S and Yokokura T. Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia. Pharmacology Biochemistry and Behavior 2001; 69: 469-474.
  39. Si Z, Sun L and Wang X Evidence and perspectives of cell senescence in neurodegenerative diseases. Biomedicine & Pharmacotherapy 2021; 137: 111327-111327.
  40. Sikora E, Bielak-Zmijewska A, Dudkowska M, Krzystyniak A, Mosieniak G, Wesierska M et al. Cellular Senescence in Brain Aging. Frontiers in Aging Neuroscience 2021; Volume 13.
  41. Streit WJ, Braak H, Del Tredici K, Leyh J, Lier J, Khoshbouei H et al. Microglial activation occurs late during preclinical Alzheimer's disease. Glia 2018; 66: 2550-2562.
  42. Tse KH and Herrup K DNA damage in the oligodendrocyte lineage and its role in brain aging. Mechanisms of Ageing and Development 2017; 161: 37-50.
  43. Wakade C, Chong R, Bradley E and Morgan JC. Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects. Clin Case Rep 2015; 3: 635-637.
  44. West M, Mhatre M, Ceballos A, Floyd RA, Grammas P, Gabbita SP et al. The arachidonic acid 5‐lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor α activation of microglia and extends survival of G93A‐SOD1 transgenic mice. Journal of Neurochemistry 2004; 91: 133-143.
  45. Wissler Gerdes EO, Zhu Y, Weigand BM, Tripathi U, Burns TC, Tchkonia T et al. Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases. International review of neurobiology 2020; 155: 203-234.
  46. Xie A, Gao J, Xu L and Meng D. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease. Biomed Res Int 2014; 2014: 648740.
  47. Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T et al. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. Protein Cell 2021; 12: 769-787.
  48. Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y and Fukunaga K. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience 2014; 259: 126-141.
  49. Yosef R, Pilpel N, Tokarsky-Amiel R, Biran A, Ovadya Y, Cohen S et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun 2016; 7: 11190.
  50. Zhang K, Chen S, Yang Q, Guo S, Chen Q, Liu Z et al. The Oligodendrocyte Transcription Factor 2 OLIG2 regulates transcriptional repression during myelinogenesis in rodents. Nat Commun 2022; 13: 1423.
  51. Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S et al. Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model. Nat Neurosci 2019; 22: 719-728.
  52. Zheng L, He S, Wang H, Li J, Liu Y and Liu S. Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies. Aging and Disease 2024; 15: 2554-2554.
Udostępnij
without publication fees
without publication fees
Zintergrowane z
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications